Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome
Background: Wolff-Parkinson-White (WPW) syndrome is a disease associated with episodes of supraventricular tachycardia and ventricular pre-excitation or atrial fibrillation. WPW is characterized by an aberrant electrical conduction pathway between atria and ventricles. Case Report: The major anes...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2015-09-01
|
Series: | Balkan Medical Journal |
Subjects: | |
Online Access: | http://balkanmedicaljournal.org/text.php?lang=en&id=210 |
id |
doaj-c4edefc9ace74833a98fee763553dffc |
---|---|
record_format |
Article |
spelling |
doaj-c4edefc9ace74833a98fee763553dffc2020-11-24T23:53:37ZengGalenos Publishing HouseBalkan Medical Journal2146-31232146-31312015-09-01323327329 10.5152/balkanmedj.2014.15155Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) SyndromeSevtap Hekimoğlu Şahin0İlhan Öztekin1Aytuna Kuzucuoğlu 2Ayça Aslanoğlu3Department of Anesthesiology and Reanimation, Trakya University Faculty of Medicine, Edirne, TurkeyDepartment of Anesthesiology and Reanimation, Trakya University Faculty of Medicine, Edirne, TurkeyDepartment of Anesthesiology and Reanimation, Trakya University Faculty of Medicine, Edirne, TurkeyDepartment of Anesthesiology and Reanimation, Trakya University Faculty of Medicine, Edirne, TurkeyBackground: Wolff-Parkinson-White (WPW) syndrome is a disease associated with episodes of supraventricular tachycardia and ventricular pre-excitation or atrial fibrillation. WPW is characterized by an aberrant electrical conduction pathway between atria and ventricles. Case Report: The major anesthetic problem connected with WPW syndrome is the risk of tachyarrhythmias due to accessory pathway. Therefore, it has been proposed that the aim of anesthetic management should be the avoidance of tachyarrhythmia and sympathetic stimulation. Sugammadex was administered as a neuromuscular reversal agent in this case. To our knowledge, this is the first case report of sugammadex use in a patient with WPW. This report presents a case of general anesthesia management in a patient with WPW syndrome. Conclusion: We think that it is appropriate to use sugammadex to reverse rocuronium for the prevention of sudden hemodynamic changes in patients with WPW who underwent general anesthesia.http://balkanmedicaljournal.org/text.php?lang=en&id=210General anesthesiasugammadexWolff-Parkinson-White syndrome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sevtap Hekimoğlu Şahin İlhan Öztekin Aytuna Kuzucuoğlu Ayça Aslanoğlu |
spellingShingle |
Sevtap Hekimoğlu Şahin İlhan Öztekin Aytuna Kuzucuoğlu Ayça Aslanoğlu Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome Balkan Medical Journal General anesthesia sugammadex Wolff-Parkinson-White syndrome |
author_facet |
Sevtap Hekimoğlu Şahin İlhan Öztekin Aytuna Kuzucuoğlu Ayça Aslanoğlu |
author_sort |
Sevtap Hekimoğlu Şahin |
title |
Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome |
title_short |
Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome |
title_full |
Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome |
title_fullStr |
Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome |
title_full_unstemmed |
Sugammadex Use in a Patient with Wolff-Parkinson-White (WPW) Syndrome |
title_sort |
sugammadex use in a patient with wolff-parkinson-white (wpw) syndrome |
publisher |
Galenos Publishing House |
series |
Balkan Medical Journal |
issn |
2146-3123 2146-3131 |
publishDate |
2015-09-01 |
description |
Background: Wolff-Parkinson-White (WPW) syndrome is a disease associated with episodes of supraventricular tachycardia and ventricular pre-excitation or atrial fibrillation. WPW is characterized by an aberrant electrical conduction pathway between atria and ventricles.
Case Report: The major anesthetic problem connected with WPW syndrome is the risk of tachyarrhythmias due to accessory pathway. Therefore, it has been proposed that the aim of anesthetic management should be the avoidance of tachyarrhythmia and sympathetic stimulation. Sugammadex was administered as a neuromuscular reversal agent in this case. To our knowledge, this is the first case report of sugammadex use in a patient with WPW. This report presents a case of general anesthesia management in a patient with WPW syndrome.
Conclusion: We think that it is appropriate to use sugammadex to reverse rocuronium for the prevention of sudden hemodynamic changes in patients with WPW who underwent general anesthesia. |
topic |
General anesthesia sugammadex Wolff-Parkinson-White syndrome |
url |
http://balkanmedicaljournal.org/text.php?lang=en&id=210 |
work_keys_str_mv |
AT sevtaphekimoglusahin sugammadexuseinapatientwithwolffparkinsonwhitewpwsyndrome AT ilhanoztekin sugammadexuseinapatientwithwolffparkinsonwhitewpwsyndrome AT aytunakuzucuoglu sugammadexuseinapatientwithwolffparkinsonwhitewpwsyndrome AT aycaaslanoglu sugammadexuseinapatientwithwolffparkinsonwhitewpwsyndrome |
_version_ |
1725468864368607232 |